LONG-TERM HEALTH RISK AFTER BREAST-CANCER RADIOTHERAPY: OVERVIEW OF PASSOS METHODOLOGY AND SOFTWARE.
Breast Neoplasms
/ radiotherapy
Dose-Response Relationship, Radiation
Female
Germany
Heart
/ radiation effects
Humans
Neoplasms, Radiation-Induced
/ etiology
Neoplasms, Second Primary
/ etiology
Organ Specificity
Organs at Risk
Radiation Injuries
/ etiology
Radiometry
Radiotherapy Dosage
Risk Assessment
Risk Factors
Software
Journal
Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958
Informations de publication
Date de publication:
01 May 2019
01 May 2019
Historique:
pubmed:
7
12
2018
medline:
5
6
2019
entrez:
7
12
2018
Statut:
ppublish
Résumé
Breast-cancer radiotherapy reduces the recurrence rates and improves patient survival. However, it also increases the incidence of second cancers and of heart disease. These radiation-induced long-term health risks become increasingly important with improved cure rates and prolonged patient survival. Radiation doses to nearby as well as distant organs strongly vary between different irradiation techniques and among individual patients. To provide personalized lifetime risk estimates, the German national project PASSOS combines individual anatomy, dosimetric estimates, organ-specific low- and high-dose risk models and personal risk factors such as smoking. A dedicated software tool is under development to assist clinical decision-making processes.
Identifiants
pubmed: 30520982
pii: 5231890
doi: 10.1093/rpd/ncy219
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
259-263Informations de copyright
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.